These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33906227)

  • 1. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection.
    Choudhary MC; Crain CR; Qiu X; Hanage W; Li JZ
    Clin Infect Dis; 2022 Jan; 74(2):237-245. PubMed ID: 33906227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
    Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
    mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
    Lee JS; Kim SY; Kim TS; Hong KH; Ryoo NH; Lee J; Park JH; Cho SI; Kim MJ; Kim YG; Kim B; Shin HS; Oh HS; Seo MS; Gwon TR; Kim Y; Park JS; Chin BS; Park WB; Park SS; Seong MW
    Clin Infect Dis; 2021 Nov; 73(9):e3002-e3008. PubMed ID: 33219681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe reinfection with severe acute respiratory syndrome coronavirus 2 in a nursing home resident: a case report.
    Bader N; Khattab M; Farah F
    J Med Case Rep; 2021 Jul; 15(1):392. PubMed ID: 34284812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy.
    Taha Y; Wardle H; Evans AB; Hunter ER; Marr H; Osborne W; Bashton M; Smith D; Burton-Fanning S; Schmid ML; Duncan CJA
    Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):85. PubMed ID: 34969393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
    Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
    Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
    Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
    Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of spike mutations following antibody treatment in two immunocompromised patients with persistent COVID-19 infection.
    Bronstein Y; Adler A; Katash H; Halutz O; Herishanu Y; Levytskyi K
    J Med Virol; 2022 Mar; 94(3):1241-1245. PubMed ID: 34755363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020.
    Lee JT; Hesse EM; Paulin HN; Datta D; Katz LS; Talwar A; Chang G; Galang RR; Harcourt JL; Tamin A; Thornburg NJ; Wong KK; Stevens V; Kim K; Tong S; Zhou B; Queen K; Drobeniuc J; Folster JM; Sexton DJ; Ramachandran S; Browne H; Iskander J; Mitruka K
    Clin Infect Dis; 2021 Dec; 73(12):2217-2225. PubMed ID: 33598716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma.
    Martínez-Barranco P; García-Roa M; Trelles-Martínez R; Arribalzaga K; Velasco M; Guijarro C; Marcos J; Campelo C; Acedo-Sanz JM; Villalón L; Ricard P; García-Bueno MJ; Pérez-Fernández E; Rodríguez-Caravaca G; Peñalver FJ
    Acta Haematol; 2022; 145(4):384-393. PubMed ID: 34839289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Associates With Unstable Housing and Occurs in the Presence of Antibodies.
    Bean DJ; Monroe J; Turcinovic J; Moreau Y; Connor JH; Sagar M
    Clin Infect Dis; 2022 Aug; 75(1):e208-e215. PubMed ID: 34755830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study.
    Turbett SE; Tomkins-Tinch CH; Anahtar MN; Dugdale CM; Hyle EP; Shenoy ES; Shaw B; Egbuonu K; Bowman KA; Zachary KC; Adams GC; Hooper DC; Ryan ET; LaRocque RC; Bassett IV; Triant VA; Siddle KJ; Rosenberg E; Sabeti PC; Schaffner SF; MacInnis BL; Lemieux JE; Charles RC
    Clin Infect Dis; 2023 Mar; 76(5):850-860. PubMed ID: 36268576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil.
    Penetra SLS; da Silva MFB; Resende P; Pina-Costa A; Santos HFP; Guaraldo L; Calvet GA; Ogrzewalska M; Arantes I; Zukeram K; de Araújo MF; Lima ABM; Lopes RS; Lira-Silva LR; Moraes IV; Wakimoto MD; Fuller TL; Gabaglia CR; Espíndola OM; Bonaldo MC; Daniel-Ribeiro CT; Whitworth J; Smith C; Nielsen-Saines K; Pauvolid-Correa A; Siqueira MM; Brasil P
    Int J Infect Dis; 2022 Jan; 114():58-61. PubMed ID: 34757006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
    Lu L; Zhang H; Zhan M; Jiang J; Yin H; Dauphars DJ; Li SY; Li Y; He YW
    Sci China Life Sci; 2020 Dec; 63(12):1833-1849. PubMed ID: 33355886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.
    Nomoto H; Kutsuna S; Okuma K; Kuramitsu M; Tezuka K; Ikebe E; Saito S; Kinoshita N; Terada M; Endo M; Suzuki T; Miyazato Y; Nakamoto T; Inada M; Hamaguchi I; Ohmagari N
    J Infect Chemother; 2021 Apr; 27(4):653-655. PubMed ID: 33487533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Importance and Challenges of Identifying SARS-CoV-2 Reinfections.
    Babiker A; Marvil CE; Waggoner JJ; Collins MH; Piantadosi A
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33361342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions.
    Bonetti TCS; Latini FRM; Invitti AL; Fonseca MCM; Scorza FA; Saldanha MG; Bellucco FT; Bacarov NBS; Soane MM; Girão MJBC
    Clinics (Sao Paulo); 2021; 76():e2818. PubMed ID: 34468538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants.
    Kubale J; Gleason C; Carreño JM; Srivastava K; Singh G; ; Gordon A; Krammer F; Simon V
    mBio; 2022 Oct; 13(5):e0178422. PubMed ID: 35997286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into SARS-CoV-2 Persistence and Its Relevance.
    Desimmie BA; Raru YY; Awadh HM; He P; Teka S; Willenburg KS
    Viruses; 2021 May; 13(6):. PubMed ID: 34072390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.